Vitiligo Excimer Laser

What Is the PALLAS Laser for Vitiligo? How Is It Different from the Excimer Laser?

PALLAS is a solid-state ultraviolet laser developed with Korean technology. In a clinical trial, 21 patients with stable vitiligo received treatment on left and right lesions with the two lasers separately over 12 weeks. The average repigmentation rate was 58.2% for PALLAS and 55.4% for the excimer laser — similar results — and there was no significant difference in safety. Although the two devices differ in medium, wavelength, and beam size, both are covered by health insurance for vitiligo on exposed areas.

Is the PALLAS laser as effective as the excimer laser?

Yes. In a clinical trial that directly compared the two lasers, the average repigmentation rate after 12 weeks was 58.2% for PALLAS and 55.4% for the excimer laser — similar effectiveness.

Our research team selected 74 pairs of symmetrical lesions from 21 patients with stable vitiligo. One side was treated with a 308 nm excimer laser and the other with a 311 nm PALLAS laser, twice a week for 12 weeks. Which side received which laser was randomly assigned, and both sides were also treated with Protopic ointment.

After 12 weeks, the average repigmentation rate and the proportion of facial lesions that achieved 75% or more repigmentation were as follows.

CategoryExcimer laserPALLAS laser
Overall repigmentation rate55.4%58.2%
Patients who completed treatment64.7%66.9%
75% or more repigmentation on the face60%65%

By body site, both lasers produced good results on the face, but neither showed significant repigmentation on the hands. This is likely because the hands are an area that typically does not respond well to ultraviolet therapy, rather than a difference between the devices.

There was also no significant difference in safety. Some patients experienced erythema lasting more than 48 hours or blisters, but the frequency was similar in both groups, and there were no adverse reactions severe enough to require discontinuation of treatment.


How Is PALLAS Different from the Conventional Excimer Laser?

The main difference between the PALLAS laser and the excimer laser is the lasing medium and wavelength. The excimer laser uses a gas medium to emit 308 nm ultraviolet light, while the PALLAS laser uses a titanium-sapphire solid crystal to produce both 311 nm and 308 nm ultraviolet light. The excimer laser requires periodic gas refills, whereas the PALLAS laser — the world's first solid-state ultraviolet laser developed with Korean technology — needs no gas refills and is easier to maintain. This advantage has led to a significant increase in clinics using targeted laser therapy for vitiligo, making it more convenient for patients to receive treatment closer to home.

CategoryExcimer laserPALLAS laser
Wavelength308nm311nm·308nm
MediumGasTitanium-sapphire solid
Treatment methodTargeted irradiation of lesionsTargeted irradiation of lesions
Beam size20×20mm12×12mm
Gas refillRequiredNot needed

Both lasers are targeted treatments that selectively deliver UV light only to vitiligo lesions. Unlike whole-body UV therapy, they reduce unnecessary UV exposure to normal skin, making them effective for patients with limited lesion areas or for cosmetically sensitive sites like the face. They can also be used safely in children who have difficulty staying alone inside a whole-body UV treatment unit.


How many PALLAS sessions are needed before results appear?

In the first study of 14 patients with vitiligo on the face and neck, repigmentation began after an average of about 5 PALLAS sessions. Patients were treated twice weekly with concurrent Protopic ointment, and 11 out of 14 patients (79%) achieved 75% or more repigmentation.

This study is a preliminary investigation by our research team, the first in the world to use the PALLAS laser for vitiligo treatment. In animal experiments, we first confirmed that skin exposed to the 311 nm PALLAS laser showed increases in substances involved in melanocyte differentiation, proliferation, and migration (such as endothelin-1, stem cell factor, and WNT7a) similar to those seen with the excimer laser. The median number of treatment sessions received by patients was 23, and the median treatment duration was approximately 3.7 months — comparable to the 3 months or more and 20–50 sessions typically needed to achieve meaningful repigmentation with the excimer laser. Three of the 14 patients achieved complete repigmentation.

The pattern of repigmentation was also similar to that of the excimer laser: pigment spread outward in spots around hair follicles (pores) or filled in from the edges of white patches inward.


PALLAS vs. Excimer Laser: Which Is Better?

In terms of treatment effectiveness for vitiligo, PALLAS and excimer lasers are comparable. Clinical studies have shown no significant differences in repigmentation outcomes or safety between the two lasers.

Like the excimer laser, PALLAS is also covered by health insurance for vitiligo on exposed areas such as the face, neck, hands, arms, and below the knees, so the out-of-pocket cost for patients is similar.

In practice, the treatment outcome depends more on the location of the vitiligo and the patient’s individual characteristics than on the type of device used. The density of hair follicles — and therefore the number of melanocyte stem cells available to supply pigment — varies by body site, so even on the same face, the response around the eyes may differ from that around the lips. If white hairs (leukotrichia) have grown within the lesion, the melanocyte stem cells may already be depleted. In that case, regardless of which laser is used, ultraviolet therapy alone has limited effectiveness, and surgical treatment may be considered.

Since the effectiveness and cost of the two lasers are similar, you can choose whichever is more convenient for you and receive treatment consistently.


References

  • Bae JM, Lee JH, Jung YS, Kim GM. The efficacy of a gain-switched 311-nm Titanium laser in the treatment of vitiligo: A pilot study of 14 patients. JAMA Dermatol. 2017;153:1055–1056

  • Bae JM, Eun SH, Lee HN, Kim GM, Grimes PE, Lee JH. Comparison of 311-nm Titanium laser and 308-nm excimer laser treatment for vitiligo: A randomized controlled non-inferiority trial. Lasers Surg Med. 2019;51:239–244

  • Bae JM, Hann SK. Laser treatments for vitiligo. Med Laser. 2016;5:63–70

Jung Min Bae, board-certified dermatologist — Gangnam Branch

Jung Min Bae

Dermatologist · Gangnam Branch

With sincere care and continuous research, I will be a reliable companion for vitiligo patients.


Request Consultation

View

WhatsApp

WhatsApp chat is for our Gangnam Branch. For other branches, please use Quick Consultation.

WhatsApp

Country code